BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 49)

Herpes: Novel treatment provides patient benefits for up to a year in clinical trials

By

A phase II clinical trial demonstrated that a new type of treatment for genital herpes, an immunotherapy called GEN-003, may reduce the activity of the virus and the number of days with recurrent herpes....

miltefosine

Amoeba treatment: Fort Worth hospital 1st in nation to have miltefosine on hand

By

Kyle Gracin Lewis died at Cook Children’s Medical Center in the summer of 2010, from the Primary Amoebic Meningoencephalitis (PAM), the brain infection caused by the water-born amoeba, known as Naegleria...

antibiotics

Treating MRSA: Rutgers scientists develop experimental antibiotic, in combination, effective in treating bacteria in animals

By

A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has...

Liraglutide decreases the risk of heart attack, stroke for people with type 2 diabetes: Study

By

Researchers have shown that the glucose-lowering drug liraglutide safely and effectively decreases the overall risk of heart attack, stroke, or cardiovascular death for people with type 2 diabetes. These...

Psoriasis drug, Ixekizumab, very effective in Phase III trials

By

About 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term clinical...

Fusobacterium: K-State researchers develop non-antibiotic treatment for humans and animals

By

A team of researchers from Kansas State University’s College of Veterinary Medicine has received a U.S. patent to control and treat fusobacterial infections in humans and animals. Created by the...

CDC on the first mcr-1 gene in E. coli bacteria found in a human in the US

By

The Centers for Disease Control and Prevention is part of a coordinated public health response after the Department of Defense (DoD) announced the discovery of the first mcr-1 gene found in bacteria in...

Multiple sclerosis (MS) drug, Zinbryta, receives FDA approval

By

The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self-...

Superbugs: mcr-1positive E. coli strain seen in Pennsylvania woman

By

The Multidrug Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR) characterized a transferrable gene for colistin resistance in the United...

Coccidioides drug, VT-1598, granted orphan drug designation

By

Viamet Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted orphan drug designation to VT-1598 for the treatment of coccidioidomycosis,...